Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company
11 2월 2014 - 6:05AM
Marketwired
Hansen Medical Announces Appointment of Chris Lowe as Interim CEO;
Bruce Barclay to Depart the Company
MOUNTAIN VIEW, CA--(Marketwired - Feb 10, 2014) - Hansen
Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular
robotics, today announced that current Board member Chris Lowe has
been appointed Interim Chief Executive Officer effective
yesterday. Mr. Lowe succeeds Bruce J. Barclay, President and
CEO since 2010. The Board of Directors has retained Russell
Reynolds Associates to conduct a search for a new CEO.
"We thank Bruce for his many contributions to Hansen Medical.
Bruce's leadership has helped position the company as a leader in
intravascular robotics," stated Mike Eagle, the Chairman of the
Board of Directors. "The Board looks forward to supporting Chris
and the management team through this transition."
Mr. Lowe is a veteran of the health care industry who joined
Hansen Medical as a Director in September 2006. Mr. Lowe's industry
roles have included serving as Chief Financial Officer and Chief
Business Officer of Anthera Pharmaceuticals (NASDAQ: ANTH),
Chief Financial Officer of Asthmatx, a medical device company
acquired by Boston Scientific and Chief Accounting Officer at
Peninsula Pharmaceuticals, acquired by Johnson & Johnson. Mr.
Lowe holds a B.S. from California Polytechnic State University, San
Luis Obispo and an M.B.A. from Saint Mary's University, Texas.
Investor Contacts: Peter J. Mariani Chief Financial Officer
Hansen Medical, Inc. 650.404.5800 Westwicke Partners, LLC. Mark
Klausner 443.213.0501 Email Contact Mike Piccinino, CFA
443.213.0509 Email Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024
Hansen Medical, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Hansen Medical, Inc. (MM) News Articles